252 related articles for article (PubMed ID: 31685549)
1. Anabolic SIRT4 Exerts Retrograde Control over TORC1 Signaling by Glutamine Sparing in the Mitochondria.
Shaw E; Talwadekar M; Rashida Z; Mohan N; Acharya A; Khatri S; Laxman S; Kolthur-Seetharam U
Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31685549
[TBL] [Abstract][Full Text] [Related]
2. SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK.
Ho L; Titus AS; Banerjee KK; George S; Lin W; Deota S; Saha AK; Nakamura K; Gut P; Verdin E; Kolthur-Seetharam U
Aging (Albany NY); 2013 Nov; 5(11):835-49. PubMed ID: 24296486
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice.
Wang YS; Du L; Liang X; Meng P; Bi L; Wang YL; Wang C; Tang B
Hepatology; 2019 Apr; 69(4):1614-1631. PubMed ID: 30552782
[TBL] [Abstract][Full Text] [Related]
4. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism.
Jeong SM; Xiao C; Finley LW; Lahusen T; Souza AL; Pierce K; Li YH; Wang X; Laurent G; German NJ; Xu X; Li C; Wang RH; Lee J; Csibi A; Cerione R; Blenis J; Clish CB; Kimmelman A; Deng CX; Haigis MC
Cancer Cell; 2013 Apr; 23(4):450-63. PubMed ID: 23562301
[TBL] [Abstract][Full Text] [Related]
5. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.
Csibi A; Fendt SM; Li C; Poulogiannis G; Choo AY; Chapski DJ; Jeong SM; Dempsey JM; Parkhitko A; Morrison T; Henske EP; Haigis MC; Cantley LC; Stephanopoulos G; Yu J; Blenis J
Cell; 2013 May; 153(4):840-54. PubMed ID: 23663782
[TBL] [Abstract][Full Text] [Related]
6. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.
Jeong SM; Lee A; Lee J; Haigis MC
J Biol Chem; 2014 Feb; 289(7):4135-44. PubMed ID: 24368766
[TBL] [Abstract][Full Text] [Related]
7. SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation.
Laurent G; de Boer VC; Finley LW; Sweeney M; Lu H; Schug TT; Cen Y; Jeong SM; Li X; Sauve AA; Haigis MC
Mol Cell Biol; 2013 Nov; 33(22):4552-61. PubMed ID: 24043310
[TBL] [Abstract][Full Text] [Related]
8. Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity.
Mathias RA; Greco TM; Oberstein A; Budayeva HG; Chakrabarti R; Rowland EA; Kang Y; Shenk T; Cristea IM
Cell; 2014 Dec; 159(7):1615-25. PubMed ID: 25525879
[TBL] [Abstract][Full Text] [Related]
9. Identification of Sirtuin4 (SIRT4) Protein Interactions: Uncovering Candidate Acyl-Modified Mitochondrial Substrates and Enzymatic Regulators.
Mathias RA; Greco TM; Cristea IM
Methods Mol Biol; 2016; 1436():213-39. PubMed ID: 27246218
[TBL] [Abstract][Full Text] [Related]
10. Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells.
Du L; Liu X; Ren Y; Li J; Li P; Jiao Q; Meng P; Wang F; Wang Y; Wang YS; Wang C
Theranostics; 2020; 10(21):9458-9476. PubMed ID: 32863939
[No Abstract] [Full Text] [Related]
11. SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism.
Cai G; Ge Z; Xu Y; Cai L; Sun P; Huang G
Sci Rep; 2022 Jul; 12(1):12208. PubMed ID: 35842463
[TBL] [Abstract][Full Text] [Related]
12. SIRT4 as a novel interactor and candidate suppressor of C-RAF kinase in MAPK signaling.
Mehrabipour M; Nakhaei-Rad S; Dvorsky R; Lang A; Verhülsdonk P; Ahmadian MR; Piekorz RP
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38499327
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial PAK6 inhibits prostate cancer cell apoptosis
Li T; Li Y; Liu T; Hu B; Li J; Liu C; Liu T; Li F
Theranostics; 2020; 10(6):2571-2586. PubMed ID: 32194820
[No Abstract] [Full Text] [Related]
14. Overexpression of mitochondrial sirtuins alters glycolysis and mitochondrial function in HEK293 cells.
de Moura MB; Uppala R; Zhang Y; Van Houten B; Goetzman ES
PLoS One; 2014; 9(8):e106028. PubMed ID: 25165814
[TBL] [Abstract][Full Text] [Related]
15. Enhanced mitochondrial glutamine anaplerosis suppresses pancreatic cancer growth through autophagy inhibition.
Jeong SM; Hwang S; Park K; Yang S; Seong RH
Sci Rep; 2016 Aug; 6():30767. PubMed ID: 27477484
[TBL] [Abstract][Full Text] [Related]
16. The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer.
Jiang W; Ouyang X; Ji Z; Shi W; Wu Y; Yao Q; Wang Y; Yang W; Xiang L; Yang H
Cancer Lett; 2023 Mar; 556():216064. PubMed ID: 36646410
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial Sirtuin 4 Resolves Immune Tolerance in Monocytes by Rebalancing Glycolysis and Glucose Oxidation Homeostasis.
Tao J; Zhang J; Ling Y; McCall CE; Liu TF
Front Immunol; 2018; 9():419. PubMed ID: 29593712
[TBL] [Abstract][Full Text] [Related]
18. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4.
Wang L; Zhou H; Wang Y; Cui G; Di LJ
Cell Death Dis; 2015 Jan; 6(1):e1620. PubMed ID: 25633289
[TBL] [Abstract][Full Text] [Related]
19. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells.
Nasrin N; Wu X; Fortier E; Feng Y; Bare' OC; Chen S; Ren X; Wu Z; Streeper RS; Bordone L
J Biol Chem; 2010 Oct; 285(42):31995-2002. PubMed ID: 20685656
[TBL] [Abstract][Full Text] [Related]
20. SIRT4 interacts with OPA1 and regulates mitochondrial quality control and mitophagy.
Lang A; Anand R; Altinoluk-Hambüchen S; Ezzahoini H; Stefanski A; Iram A; Bergmann L; Urbach J; Böhler P; Hänsel J; Franke M; Stühler K; Krutmann J; Scheller J; Stork B; Reichert AS; Piekorz RP
Aging (Albany NY); 2017 Oct; 9(10):2163-2189. PubMed ID: 29081403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
